A Single-Dose Pharmacokinetics and Safety Study of TMC278 in Healthy Adult Japanese Participants
Clinical trial NCT01804244 · COMPLETED
Trial details
- NCT number
- NCT01804244
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-01
- Primary completion
- 2013-03-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.